Company: AEMD
Filing Date: 2025-08-29
Form Type: S-1/A
Source: 0001683168-25-006537
Chunk: 3

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-29
Form: S-1/A
Chunk 3
---
 For each pre-funded warrant purchased in this Company Offering in lieu of common stock, we will reduce the number of shares of
common stock we are offering by one. Pursuant to this prospectus, we are also offering the shares of common stock issuable upon the exercise
of the warrants, pre-funded warrants and placement agent warrants offered hereby.

Each share of our common
stock, or pre-funded warrant in lieu thereof, is being sold together with a warrant to purchase one share of our common stock. Each
warrant will have an exercise price of $ per share (representing 100% of the combined public offering price per share of common
stock (or pre-funded warrant) and accompanying warrant in this offering), will be immediately exercisable and will expire on the
fifth anniversary of the original issuance date. The shares of our common stock and warrants are immediately separable and will be
issued separately, but will be purchased together in this Company Offering. The pre-funded warrants and warrants are not listed on
any trading market and we do not intend to apply for listing of these pre-funded warrants and warrants. Without an active market,
the liquidity of these warrants will be limited.

This Company Offering will
terminate on within one year of the effective date, unless we decide to terminate (which we may do at any time in our discretion) prior
to that date. We will have one closing for all the securities purchased in this Company Offering by us. The combined public offering price
per share (or pre-funded warrant) and warrant will be fixed for the duration of this Company Offering.

We have engaged Maxim Group LLC,
or the placement agent, to act as our exclusive placement agent in connection with the securities offered by the Company in the Company
Offering. The placement agent has agreed to use its reasonable best efforts to arrange for the sale of the securities offered in the Company
Offering in this prospectus. Other than the placement agent warrants issued as compensation, the placement agent is not purchasing or
selling any of the securities we are offering, and the placement agent is not required to arrange the purchase or sale of any specific
number of securities or dollar amount.

In addition, this prospectus also
relates to the resale from time to time, by the selling securityholders (the “Inducement Offering”) identified in this prospectus
under the caption “Selling Securityholders” of up to 1,550,000 shares of our common stock which are issuable
upon the exercise of outstanding inducement warrants